Table 2.
Variables | Total N = 282 |
---|---|
Monomicrobial pneumonia (S. maltophilia only) (n, (%)) | 117 (41.6) |
Other microorganisms identified (polymicrobial) (n, (%)) | |
Acinetobacter baumanii | 7 (4.3) |
Citrobacter spp. | 7 (4.3) |
Enterobacter spp. | 30 (18.3) |
Enterococcus spp. | 6 (3.7) |
Escherichia coli | 25 (15.2) |
Haemophilus | 3 (1.8) |
Hafnia alvei | 3 (1.8) |
Klebsiella spp. | 25 (15.2) |
Methicillin-resistant Staphylococcus aureus | 3 (1.8) |
Methicillin-sensitive Staphylococcus aureus | 13 (7.9) |
Morganella morganii | 1 (0.6) |
Proteus spp. | 7 (4.3) |
Pseudomonas aeruginosa | 49 (29.9) |
Serratia spp. | 8 (4.9) |
Streptococcus spp. | 1 (0.6) |
Others | 10 (6.1) |
S. maltophilia pneumonia-related manifestations (n, (%)) | |
Associated bacteremia | 20 (7.1) |
Associated empyema thoracis | 25 (8.9) |
Associated septic shock | 123 (43.6) |
Total number of days of norepinephrine infusion (median [IQR]) | 0 [0–6] |
Severity of pneumonia | |
Oxygenation level regarding S. maltophilia HAP (n, (%)) | |
Hypoxemia with PaO2/FIO2 > 300 mmHg with PEEP ≥ 5 cmH2O | 45 (16) |
Mild ARDS | 98 (34.7) |
Moderate ARDS | 101 (35.8) |
Severe ARDS | 36 (12.7) |
Prone positioning (n, (%)) | 13 (4.6) |
ECMO requirement | 15 (5.3) |
Veno-venous | 8 (53.3) |
Veno-arterial | 7 (46.7) |
Data is presented as number (%) or median [IQR]. Mild ARDS (200 mmHg < PaO2/FiO2 ≤ 300 mmHg with PEEP ≥ 5 cmH2O), moderate ARDS (100 mmHg < PaO2/FiO2 ≤ 200 mmHg with PEEP ≥ 5 cmH2O), severe ARDS (PaO2/FiO2 ≤ 100 mmHg with PEEP ≥ 5 cmH2O)
S. maltophilia, Stenotrophomonas maltophilia; ARDS, Acute Respiratory Distress Syndrome, was defined according to the Berlin definition; PEEP, positive end-expiratory pressure